Grifols Shares Jump After Report on Takeover Talks Resuming
MADRID, April 2 (Reuters) - Shares in Grifols jumped sharply on Wednesday morning after news website El Confidencial reported that Canadian fund Brookfield has resumed takeover talks with the Spanish pharmaceuticals company.
US-listed shares of Grifols jumped 8.8% in premarket trading Wednesday.
Brookfield has contacted the Grifols family and is considering making an offer valuing the company at 7 billion euros ($7.55 billion), El Confidencial said, adding that the investment fund is being advised by Morgan Stanley.
A non-binding offer that valued Grifols at 6.7 billion euros was withdrawn by Brookfield in November after Grifols management rejected the bid as too low and recommended shareholders keep their shares.
The Grifols family, the company's largest shareholder, declined to comment. Brookfield representatives and Morgan Stanley did not respond immediately to requests for comment.
($1 = 0.9266 euros)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10